Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $2.9, expectations were $2.86. Operator: Thank you for standing by. My name ...
businessday9h
Nigeria to Houston: Osuorah pursues sustainable solutions to address increasing complexity of cyber threats
Josemaria Osuorah is a software engineer and a current machine learning and cybersecurity PhD student in Praire View A&M ...
Business Wire18h
6sense Releases State of the BDR 2025 Research Report, Revealing AI's Positive Impact on Sales Development
SAN FRANCISCO-- ( BUSINESS WIRE )-- 6sense ®, the leading platform revolutionizing B2B revenue generation, today released its ...
GE HealthCare: Medical Imaging Giant Now Finding Its Footing to Stand Alone
Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...
Bio-Rad's Expanding Profit Margins and Stake in Sartorius Drive Long-Term Value
As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...